• Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue

Eli Lilly’s Lyumjev receives FDA approval

14/09/2021 No Comments

Eli Lilly has received FDA approval and expanded labelling for its Lyumjev rapid-acting insulin. Lyumjev is a novel formulation of insulin lispro for speeding up

Read More »

Eli Lilly buys ‘smart insulin’ company in huge investment

31/08/2021 No Comments

On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is

Read More »

Eli Lilly buys ‘smart insulin’ company in huge investment

16/07/2021 No Comments

On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is

Read More »

KIT REPORT: Lilly, Ypsomed and an AID system

16/12/2020 No Comments

Eli Lilly, one of the Big Three insulin makers that’s had its eyes on diabetes technology for several years, is making moves to launch a

Read More »

App aid for insulin dosing (coming soon)

28/06/2017 No Comments

Lilly’s Go Dose app for adjusting Humalog (mealtime) insulin received FDA clearance in January; launch timing has not been announced. Lynn Kennedy and Adam Brown

Read More »

Adocia (fast-acting insulin backed by Eli Lilly) on hold

13/04/2017 No Comments

Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6

Read More »

Dulaglutide — new Lilly injectable

30/11/2012 No Comments

Eli Lilly & Co says its once-weekly injectible drug, dulaglutide, has outperformed three other widely taken drugs in three just-concluded Phase III studies. According to

Read More »

Eli Lilly and JDRF to fund research into beta cell regeneration

17/02/2011 No Comments

Eli Lilly and Company (NYSE: LLY) and the Juvenile Diabetes Research Foundation (JDRF) announced in early February 2011 that they have signed an agreement to

Read More »

Follow us elsewhere

Facebook Twitter Instagram

Latest tweets

Twitter: desangsue
Sue Marshall
  • Weather warning to people living with diabetes from Diabetes UK - https://t.co/BxFbhfqMQm 06:17:09 PM July 14, 2022
@desangsue

Recent posts

Identification of disease-causing proteins leads to possible treatments for diseases like diabetes

Insulet acquires insulin pump patents from Bigfoot Biomedical

NHS diabetes prevention programme lowers numbers developing T2D

  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Menu
  • Home
  • News
  • Kitbags
  • Contact
  • Diabetes Directory
  • Latest issue
Site by Loopmill